# SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
> **ANDA219429** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2026-08-31
## Drug
- **FDA Application Number:** ANDA219429
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
- **Generic name:** Magnesium Sulfate
- **Active ingredients:** MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **First approval:** 2026-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219429)
---
*MORVS · CC0 1.0*